Endocrine System Diseases  >>  PF-04856883  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-04856883 / Pfizer
NCT00886821: A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics

Completed
1
114
US
CVX-096
Pfizer
Diabetes Mellitus, Type 2
06/11
06/11
NCT01301456: Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

Completed
1
84
US
Placebo, PF-04856883, CVX-096
Pfizer
Diabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders, Metabolic Diseases, Endocrine System Diseases
12/11
04/12

Download Options